Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Ichnos Glenmark Innovation (IGI), a global, fully integrated clinical-stage biotechnology company focused on developing ...

Building on these data, the preclinical PK model tracked the plasma levels of the CD38-SADA protein. Importantly, the model's estimated linear clearance of low molecular weight CD38-SADA monomers was ...

Building on these data, the preclinical PK model tracked the plasma levels of the CD38-SADA protein. Importantly, the model’s estimated linear clearance of low molecular weight CD38-SADA ...

Building on these data, the preclinical PK model tracked the plasma levels of the CD38-SADA protein. Importantly, the model’s estimated linear clearance of low molecular weight CD38-SADA ...

Cytopenias: low levels of red blood cells ... Darzalex, according to the National Cancer Institute, binds to the protein CD38 found on some types of immune cells and cancer cells, including myeloma ...

Looking to fuel your body with high-protein, low-calorie foods? You’re in the right place. Whether you're aiming to build muscle, lose weight sustainably, or simply make smarter food choices ...

MSCs were shown to constitutively express low levels of c-kit which could be en-hanced by SCF. G-CSF and SCF had an obvious facilitative effect on the proliferation of MSCs in a dose-dependent fashion ...

due to the low uptake of sUA in these cells. Pharmacological blockage in THP-1 cells provides mechanistic evidence that sUA inhibits NLRP3-mediated secretion of IL-1β through CD38, but genetic ...